Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Hank who wrote (6199)	2/16/1999 1:53:00 PM
From: Linda Kaplan	Read Replies (2) \| Respond to of 7041

Turns out that one of the releases indicated that sales for Mexico this quarter were minus 4,000. So the first quarter there were sales, they sold 167,170 units, claiming they were just starting out and would build up stronger. The second quarter there were sales to Mexico there were zero additional sales and the third quarter, the one just reported, that there were sales to Mexico, there were MINUS 4,000. That means there were returns of 4,000 and that for all three quarters there were only 163,170 units sold. No sales for the second quarter in a row, they stuffed the channel in the first quarter and may be riding on those initial sales forever. Whoever has been saying that sales in Mexico are "great" was lying or mistaken. Linda

To: Hank who wrote (6199)	2/16/1999 2:58:00 PM
From: Bob Trocchi	Read Replies (2) \| Respond to of 7041

Hank... >>Beautiful. Sounds like they didn't sell a single pill of Vasoscam in the fourth quarter<< Come on now Hank, read the whole story correctly. It clearly states that they had royalty revenue of $163K for 1998 from Vasomax in Mexico. Now $160k is a $652k run rate for a full year. Lets give some growth and figure it is a $1M yearly run rate. Not bad for a company that reports losing $6.0M in this Q!! Zona's biggest claim to fame is that they have a cash balance of $51M ( that was in the PR)and that alone can carry them for a couple of years even if they never sell Vasomax or get US FDA approval. They sure may not have sold a lot of Vasomax but they have sure sold a lot of hype and have been very successful in getting investors to depart with their money! Bob T. (currently short)